202 related articles for article (PubMed ID: 25286826)
1. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
2. Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy.
Müller U; Hentschel J; Janhsen WK; Hünniger K; Hipler UC; Sonnemann J; Pfister W; Böer K; Lehmann T; Mainz JG
Mediators Inflamm; 2015; 2015():626530. PubMed ID: 26185365
[TBL] [Abstract][Full Text] [Related]
3. Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases.
Hentschel J; Müller U; Doht F; Fischer N; Böer K; Sonnemann J; Hipler C; Hünniger K; Kurzai O; Markert UR; Mainz JG
J Immunol Methods; 2014 Feb; 404():41-51. PubMed ID: 24370751
[TBL] [Abstract][Full Text] [Related]
4. Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.
Janhsen WK; Arnold C; Hentschel J; Lehmann T; Pfister W; Baier M; Böer K; Hünniger K; Kurzai O; Hipler UC; Mainz JG
Med Microbiol Immunol; 2016 Oct; 205(5):485-500. PubMed ID: 27377929
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
Weldon S; McNally P; McElvaney NG; Elborn JS; McAuley DF; Wartelle J; Belaaouaj A; Levine RL; Taggart CC
J Immunol; 2009 Dec; 183(12):8148-56. PubMed ID: 20007580
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients.
Gaggar A; Li Y; Weathington N; Winkler M; Kong M; Jackson P; Blalock JE; Clancy JP
Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L96-L104. PubMed ID: 17384080
[TBL] [Abstract][Full Text] [Related]
7. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
8. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
[TBL] [Abstract][Full Text] [Related]
9. Anti-protease levels in cystic fibrosis are associated with lung function, recovery from pulmonary exacerbations and may be gender-related.
Essilfie AT; Houston N; Maniam P; Hartel G; Okano S; Reid DW
Respirology; 2023 Jun; 28(6):533-542. PubMed ID: 36642534
[TBL] [Abstract][Full Text] [Related]
10. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
[TBL] [Abstract][Full Text] [Related]
11. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
12. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
14. Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease.
Belkowski SM; Boot JD; Mascelli MA; Diamant Z; de Garavilla L; Hertzog B; Polkovitch D; Towers M; Batheja A; D'Andrea MR
Clin Exp Allergy; 2009 Aug; 39(8):1179-86. PubMed ID: 19400896
[TBL] [Abstract][Full Text] [Related]
15. Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.
Jackson PL; Xu X; Wilson L; Weathington NM; Clancy JP; Blalock JE; Gaggar A
Mol Med; 2010; 16(5-6):159-66. PubMed ID: 20111696
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive assessment of upper and lower airway infection and inflammation in CF patients.
Fischer N; Hentschel J; Markert UR; Keller PM; Pletz MW; Mainz JG
Pediatr Pulmonol; 2014 Nov; 49(11):1065-75. PubMed ID: 24464968
[TBL] [Abstract][Full Text] [Related]
17. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
Sagel SD; Sontag MK; Accurso FJ
Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
[TBL] [Abstract][Full Text] [Related]
18. The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung.
Twigg MS; Brockbank S; Lowry P; FitzGerald SP; Taggart C; Weldon S
Mediators Inflamm; 2015; 2015():293053. PubMed ID: 26185359
[TBL] [Abstract][Full Text] [Related]
19. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
[TBL] [Abstract][Full Text] [Related]
20. A secretory leukocyte protease inhibitor variant with improved activity against lung infection.
Camper N; Glasgow AM; Osbourn M; Quinn DJ; Small DM; McLean DT; Lundy FT; Elborn JS; McNally P; Ingram RJ; Weldon S; Taggart CC
Mucosal Immunol; 2016 May; 9(3):669-76. PubMed ID: 26376365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
